Re-usable Respimat® Soft MistTM Inhaler Study
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: Respimat
- First Posted Date
- 2019-07-08
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 262
- Registration Number
- NCT04011735
- Locations
- 🇳🇴
Svelvik Legesenter, Svelvik, Norway
🇩🇰Hvidovre Hospital, Hvidovre, Denmark
🇧🇪Clinique Notre-Dame de Grâce, Gosselies, Belgium
A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy
- First Posted Date
- 2019-06-28
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT04002310
- Locations
- 🇺🇸
Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States
🇺🇸Retina Specialty Institute, Pensacola, Florida, United States
🇺🇸Center for Retina and Macular Disease, Winter Haven, Florida, United States
This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Non-vitamin K antagonist oral anticoagulant
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 500
- Registration Number
- NCT03993119
- Locations
- 🇪🇸
H. de Mataró, Mataró, Barcelona, Spain
🇪🇸H. Fundación Alcorcón, Alcorcón, Madrid, Spain
🇪🇸Consulta Privada, Valencia, Spain
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26774
- Registration Number
- NCT03993132
- Locations
- 🇩🇰
Department of Clinical Epidemiology - Aarhus Unversiteteshospital, Aarhus, Denmark
A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT03988803
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany
A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: Olodaterol/Tiotropium Bromide
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 11296
- Registration Number
- NCT03979807
- Locations
- 🇺🇸
Aetion Inc., New York, New York, United States
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 53
- Registration Number
- NCT03979820
- Locations
- 🇳🇱
PRA Health Sciences Onderzoekscentrum Martini, Groningen, Netherlands
Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 68
- Registration Number
- NCT03971539
- Locations
- 🇩🇪
Fraunhofer ITEM, Hannover, Germany
A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 21
- Registration Number
- NCT03972150
- Locations
- 🇯🇵
Shizuoka Cancer Center, Shizuoka, Sunto-gun, Japan
🇯🇵National Cancer Center Hospital, Tokyo, Chuo-ku, Japan
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 61
- Registration Number
- NCT03971695
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany